Sampson JH - Search Results

1

Brain Tumor Microenvironment and Host State: Implications for Immunotherapy.

Tomaszewski W, Sanchez-Perez L, Gajewski TF, Sampson JH. Tomaszewski W, et al. Among authors: sampson jh. Clin Cancer Res. 2019 Jul 15;25(14):4202-4210. doi: 10.1158/1078-0432.CCR-18-1627. Epub 2019 Feb 25. Clin Cancer Res. 2019. PMID: 30804019 Free PMC article. Review.

2

Treatment of neoplastic meningitis with intrathecal temozolomide.

Sampson JH, Archer GE, Villavicencio AT, McLendon RE, Friedman AH, Bishop WR, Bigner DD, Friedman HS. Sampson JH, et al. Clin Cancer Res. 1999 May;5(5):1183-8. Clin Cancer Res. 1999. PMID: 10353755

3

Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1.

Archer GE, Sampson JH, Lorimer IA, McLendon RE, Kuan CT, Friedman AH, Friedman HS, Pastan IH, Bigner DD. Archer GE, et al. Among authors: sampson jh. Clin Cancer Res. 1999 Sep;5(9):2646-52. Clin Cancer Res. 1999. PMID: 10499644

4

Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats.

Heimberger AB, Archer GE, McLendon RE, Hulette C, Friedman AH, Friedman HS, Bigner DD, Sampson JH. Heimberger AB, et al. Among authors: sampson jh. Clin Cancer Res. 2000 Oct;6(10):4148-53. Clin Cancer Res. 2000. PMID: 11051269

5

Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa).

Heimberger AB, Learn CA, Archer GE, McLendon RE, Chewning TA, Tuck FL, Pracyk JB, Friedman AH, Friedman HS, Bigner DD, Sampson JH. Heimberger AB, et al. Among authors: sampson jh. Clin Cancer Res. 2002 Nov;8(11):3496-502. Clin Cancer Res. 2002. PMID: 12429640

6

Clinical immunotherapy for brain tumors.

Fecci PE, Sampson JH. Fecci PE, et al. Among authors: sampson jh. Neuroimaging Clin N Am. 2002 Nov;12(4):641-64. doi: 10.1016/s1052-5149(02)00027-8. Neuroimaging Clin N Am. 2002. PMID: 12687917 Review.

7

Adoptive immunotherapy for malignant glioma.

Mitchell DA, Fecci PE, Sampson JH. Mitchell DA, et al. Among authors: sampson jh. Cancer J. 2003 May-Jun;9(3):157-66. doi: 10.1097/00130404-200305000-00004. Cancer J. 2003. PMID: 12952301 Review.

8

Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer.

Grossi PM, Ochiai H, Archer GE, McLendon RE, Zalutsky MR, Friedman AH, Friedman HS, Bigner DD, Sampson JH. Grossi PM, et al. Among authors: sampson jh. Clin Cancer Res. 2003 Nov 15;9(15):5514-20. Clin Cancer Res. 2003. PMID: 14654531

9

Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme.

Learn CA, Hartzell TL, Wikstrand CJ, Archer GE, Rich JN, Friedman AH, Friedman HS, Bigner DD, Sampson JH. Learn CA, et al. Among authors: sampson jh. Clin Cancer Res. 2004 May 1;10(9):3216-24. doi: 10.1158/1078-0432.ccr-03-0521. Clin Cancer Res. 2004. PMID: 15131063

10

Treatment of intracerebral neoplasia and neoplastic meningitis with regional delivery of oncolytic recombinant poliovirus.

Ochiai H, Moore SA, Archer GE, Okamura T, Chewning TA, Marks JR, Sampson JH, Gromeier M. Ochiai H, et al. Among authors: sampson jh. Clin Cancer Res. 2004 Jul 15;10(14):4831-8. doi: 10.1158/1078-0432.CCR-03-0694. Clin Cancer Res. 2004. PMID: 15269159

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

331 results

Search Page